Literature DB >> 33402821

Improved in vitro and in vivo Anti-Candida albicans Activity of Cymbopogon nardus Essential Oil by Its Incorporation into a Microemulsion System.

Luciani Gaspar de Toledo1, Matheus Aparecido Dos Santos Ramos1, Patrícia Bento da Silva2, Camila Fernanda Rodero3, Veridiana de Sá Gomes1, Anderson Noronha da Silva1, Fernando Rogério Pavan1, Isabel Cristiane da Silva1, Fernando Bombarda Oda4, Danilo Luis Flumignan5, André Gonzaga Dos Santos4, Marlus Chorilli3, Margarete Teresa Gottardo de Almeida6, Taís Maria Bauab1.   

Abstract

PURPOSE: Vulvovaginal candidiasis (VVC) is an opportunistic fungal infection that adversely affects a woman's health, due to unpleasant symptoms, therapeutic challenges, and the emergence of resistant strains. The association of natural products and nanotechnology is important to improve the antifungal potential of medicinal plants. We aimed to evaluate the in vitro and in vivo anti-Candida albicans activity of unloaded (EO) and loaded (ME+EO) essential oil of Cymbopogon nardus in the microemulsion (ME).
METHODS: The chemical analysis of the EO was performed by gas chromatography-mass spectrometry. The ME and ME+EO were characterized by scattering, zeta potential, polarized light microscopy, rheological assays, mucoadhesiveness and transmission electronic microscopy. The in vitro antifungal activity of the EO and ME+EO were evaluated by microdilution technique. The toxicity of EO and ME+EO was analyzed on human cell line HaCat and using alternative model assay with Artemia salina. The experimental in vivo VVC was performed in female mice (C57BL/6).
RESULTS: The main compounds of the EO were found to be citronellal, geranial, geraniol, citronellol, and neral. The formulations exhibited suitable size, homogeneity, negative charge, isotropic behavior, highly organized structure, and pseudoplastic behavior, for vaginal application. TEM photomicrographs showed possible EO droplets inside the spherical structures. The EO, when loaded into the ME, exhibited an improvement in its antifungal action against C. albicans. The EO was not toxic against brine shrimp nauplii. An in vivo VVC assay showed that the use of the ME significantly improved the action of the EO, since only the ME+EO promoted the eradication of the fungal vaginal infection on the third day of treatment.
CONCLUSION: The EO and ME+EO are promising alternatives for the control of fungal infections caused by C. albicans, once the use of nanotechnology significantly improved the antifungal action of the EO, especially in an in vivo model of VVC.
© 2020 Gaspar de Toledo et al.

Entities:  

Keywords:  citronella; nanostructured lipid system; therapeutic treatment; vulvovaginal candidiasis

Mesh:

Substances:

Year:  2020        PMID: 33402821      PMCID: PMC7778679          DOI: 10.2147/IJN.S275258

Source DB:  PubMed          Journal:  Int J Nanomedicine        ISSN: 1176-9114


  64 in total

1.  Comparative study of the assay of Artemia salina L. and the estimate of the medium lethal dose (LD50 value) in mice, to determine oral acute toxicity of plant extracts.

Authors:  A Logarto Parra; R Silva Yhebra; I Guerra Sardiñas; L Iglesias Buela
Journal:  Phytomedicine       Date:  2001-09       Impact factor: 5.340

2.  Antimicrobial activity of clove oil and its potential in the treatment of vaginal candidiasis.

Authors:  N Ahmad; M K Alam; A Shehbaz; A Khan; A Mannan; S Rashid Hakim; D Bisht; M Owais
Journal:  J Drug Target       Date:  2005-12       Impact factor: 5.121

Review 3.  Role of mini-host models in the study of medically important fungi.

Authors:  Georgios Chamilos; Michail S Lionakis; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Lancet Infect Dis       Date:  2007-01       Impact factor: 25.071

4.  Clotrimazole multiple W/O/W emulsion as anticandidal agent: Characterization and evaluation on skin and mucosae.

Authors:  José L Soriano-Ruiz; Joaquim Suñer-Carbó; Ana C Calpena-Campmany; Nuria Bozal-de Febrer; Lyda Halbaut-Bellowa; Antonio Boix-Montañés; Eliana B Souto; Beatriz Clares-Naveros
Journal:  Colloids Surf B Biointerfaces       Date:  2018-11-29       Impact factor: 5.268

5.  Toxic essential oils. Part III: identification and biological activity of new allylmethoxyphenyl esters from a Chamomile species (Anthemis segetalis Ten.).

Authors:  Niko S Radulović; Marko Z Mladenović; Polina D Blagojević; Zorica Z Stojanović-Radić; Tatjana Ilic-Tomic; Lidija Senerovic; Jasmina Nikodinovic-Runic
Journal:  Food Chem Toxicol       Date:  2013-09-18       Impact factor: 6.023

Review 6.  Nanotechnology-based drug delivery systems for control of microbial biofilms: a review.

Authors:  Matheus Aparecido Dos Santos Ramos; Patrícia Bento Da Silva; Larissa Spósito; Luciani Gaspar De Toledo; Bruna Vidal Bonifácio; Camila Fernanda Rodero; Karen Cristina Dos Santos; Marlus Chorilli; Taís Maria Bauab
Journal:  Int J Nanomedicine       Date:  2018-02-27

7.  Inhibition of adherence of C. albicans to dental implants and cover screws by Cymbopogon nardus essential oil and citronellal.

Authors:  Leonardo Antunes Trindade; Julyana de Araújo Oliveira; Ricardo Dias de Castro; Edeltrudes de Oliveira Lima
Journal:  Clin Oral Investig       Date:  2015-03-26       Impact factor: 3.573

8.  Sensitivity of Candida albicans to essential oils: are they an alternative to antifungal agents?

Authors:  E Bona; S Cantamessa; M Pavan; G Novello; N Massa; A Rocchetti; G Berta; E Gamalero
Journal:  J Appl Microbiol       Date:  2016-10-24       Impact factor: 3.772

9.  Co-loaded paclitaxel/rapamycin liposomes: Development, characterization and in vitro and in vivo evaluation for breast cancer therapy.

Authors:  Josimar O Eloy; Raquel Petrilli; José Fernando Topan; Heriton Marcelo Ribeiro Antonio; Juliana Palma Abriata Barcellos; Deise L Chesca; Luciano Neder Serafini; Daniel G Tiezzi; Robert J Lee; Juliana Maldonado Marchetti
Journal:  Colloids Surf B Biointerfaces       Date:  2016-01-22       Impact factor: 5.268

10.  Nanostructured lipid system as a strategy to improve the anti-Candida albicans activity of Astronium sp.

Authors:  Bruna Vidal Bonifácio; Matheus Aparecido dos Santos Ramos; Patrícia Bento da Silva; Kamila Maria Silveira Negri; Érica de Oliveira Lopes; Leonardo Perez de Souza; Wagner Vilegas; Fernando Rogério Pavan; Marlus Chorilli; Taís Maria Bauab
Journal:  Int J Nanomedicine       Date:  2015-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.